Bever Pharmaceutical Pte. Ltd., Pharmstandard deal

Pharmstandard completed the acquisition of Bever for $590 million comprised of $542 million in global depositary receipts (GDRs) and $48 million in cash. Pharmstandard expects to include Bever in the ...